WC
BBIO icon

Whitney & Co’s BridgeBio Pharma BBIO Stock Holding History

Whitney & Co’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Hold
5,050
– – 0.03% 136
2026
Q1 		$375K Buy
5,050
+1,700
+51% +$123K 0.03% 134
2025
Q4 		$256K Sell
3,350
-4,150
-55% -$272K 0.02% 153
2025
Q3 		$390K Sell
7,500
-1,600
-18% -$78K 0.04% 103
2025
Q2 		$393K Buy
9,100
+550
+6% +$20K 0.04% 99
2025
Q1 		$296K Buy
+8,550
New +$288K 0.03% 112

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Whitney & Co's BBIO Position: Q2 2026 in Review

Whitney & Co held its BridgeBio Pharma (BBIO) position steady in Q2 2026 at 5,050 shares worth $376K. The position accounts for 0.03% of the portfolio, ranked #136.

Whitney & Co first reported a position in BBIO in Q1 2025 and has held it in 6 quarters since. The position peaked at $393K in Q2 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Whitney & Co held 5,050 shares of BridgeBio Pharma worth $376K as of Q2 2026.
  • Whitney & Co left its BridgeBio Pharma share count unchanged in Q2 2026.
  • BridgeBio Pharma made up 0.03% of Whitney & Co's portfolio in Q2 2026, its #136 holding.
  • Whitney & Co first reported a position in BridgeBio Pharma in Q1 2025 and has held it in 6 quarters since.
  • Whitney & Co's BridgeBio Pharma position peaked at $393K in Q2 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Whitney & Co's 13F filing for Q2 2026, filed 28 Jul 2026.